课题基金 / 基金详情

DNA demethylation blockers; novel preventive and therapeutic approach to breast cancer development, progression and metastasis

DNA demethylation blockers; novel preventive and therapeutic approach to breast cancer development, progression and metastasis
DNA 去甲基化阻断剂；
批准号：
279668
负责人：
Rabbani Shafaat A
金额：
$58.14万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-03-01 至 2018-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=279668&lang=en
关键词：
Breast Cancer Dna Methylation Transgenic Mice Tumor Metastasis

项目摘要

项目成果

Rabbani Shafaat A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Metastasis of cancer cells to other organs is responsible for a large fraction of the morbidity and mortality from breast cancer. There are no effective therapies that could block breast cancer metastasis. A large number of genes play a role in breast can
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of methyl-CpG-binding domain protein 2 (Mbd2) in breast cancer development, progression and metastasis
Targeting methyl-CpG-binding domain protein 2 (Mbd2) towards the development of next generation precision Epi-therapies against metastatic breast cancer
Targeting methyl-CpG-binding domain protein 2 (Mbd2) towards the development of next generation precision Epi-therapies against metastatic breast cancer
Urokinase plasminogen activator (uPA) and its receptor (uPAR) interaction in tumor microenvironment, therapeutic implications
海外基金